Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of FXR in Liver Inflammation During Nonalcoholic Steatohepatitis
Laura E. Armstrong, Grace L. Guo
Current Pharmacology Reports (2017) Vol. 3, Iss. 2, pp. 92-100
Open Access | Times Cited: 81

Showing 1-25 of 81 citing articles:

From NASH to HCC: current concepts and future challenges
Quentin M. Anstee, Helen L. Reeves, Elena Kotsiliti, et al.
Nature Reviews Gastroenterology & Hepatology (2019) Vol. 16, Iss. 7, pp. 411-428
Closed Access | Times Cited: 1133
The Gut Microbial Bile Acid Modulation and Its Relevance to Digestive Health and Diseases
Kelly Fogelson, Pieter C. Dorrestein, Amir Zarrinpar, et al.
Gastroenterology (2023) Vol. 164, Iss. 7, pp. 1069-1085
Open Access | Times Cited: 66
FXR agonists in NASH treatment
Luciano Adorini, Michael Trauner
Journal of Hepatology (2023) Vol. 79, Iss. 5, pp. 1317-1331
Open Access | Times Cited: 46
Nuclear receptors are the major targets of endocrine disrupting chemicals
Lucia Toporová, Patrick Balaguer
Molecular and Cellular Endocrinology (2019) Vol. 502, pp. 110665-110665
Open Access | Times Cited: 134
Genetic analysis in European ancestry individuals identifies 517 loci associated with liver enzymes
Raha Pazoki, Marijana Vujković, Joshua Elliott, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 91
The Molecular and Mechanistic Insights Based on Gut–Liver Axis: Nutritional Target for Non-Alcoholic Fatty Liver Disease (NAFLD) Improvement
Yun Ji, Yue Yin, Lijun Sun, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 9, pp. 3066-3066
Open Access | Times Cited: 88
Metagenomic analysis of the human microbiome reveals the association between the abundance of gut bile salt hydrolases and host health
Baolei Jia, Dongbin Park, Yoonsoo Hahn, et al.
Gut Microbes (2020) Vol. 11, Iss. 5, pp. 1300-1313
Open Access | Times Cited: 84
The Race to Bash NASH: Emerging Targets and Drug Development in a Complex Liver Disease
F. Anthony Romero, Christopher T. Jones, Ying‐zi Xu, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 10, pp. 5031-5073
Closed Access | Times Cited: 80
Alteration of Gut Microbiota Composition in the Progression of Liver Damage in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Alejandra Zazueta, Lucía Valenzuela-Pérez, Nicolás Ortiz‐López, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4387-4387
Open Access | Times Cited: 10
Nonalcoholic Fatty Liver Disease (NAFLD) as Model of Gut–Liver Axis Interaction: From Pathophysiology to Potential Target of Treatment for Personalized Therapy
Francesca Fianchi, Antonio Liguori, Antonio Gasbarrini, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 12, pp. 6485-6485
Open Access | Times Cited: 52
Connecting the Dots Between Inflammatory Bowel Disease and Metabolic Syndrome: A Focus on Gut-Derived Metabolites
Andrea Verdugo‐Meza, Jiayu Ye, Hansika Dadlani, et al.
Nutrients (2020) Vol. 12, Iss. 5, pp. 1434-1434
Open Access | Times Cited: 51
Mast Cells Regulate Ductular Reaction and Intestinal Inflammation in Cholestasis Through Farnesoid X Receptor Signaling
Vik Meadows, Lindsey Kennedy, Burcin Ekser, et al.
Hepatology (2021) Vol. 74, Iss. 5, pp. 2684-2698
Open Access | Times Cited: 48
Molecular and Pathophysiological Links between Metabolic Disorders and Inflammatory Bowel Diseases
Chang‐Kee Hyun
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9139-9139
Open Access | Times Cited: 43
Corosolic acid ameliorates non‐alcoholic steatohepatitis induced by high‐fat diet and carbon tetrachloride by regulating TGF‐β1/Smad2, NF‐κB, and AMPK signaling pathways
Guancheng Liu, Zhe Cui, Xiaoyan Gao, et al.
Phytotherapy Research (2021) Vol. 35, Iss. 9, pp. 5214-5226
Closed Access | Times Cited: 41
MASLD treatment—a shift in the paradigm is imminent
Mariana Verdelho Machado
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 16
Shedding light on non-alcoholic fatty liver disease: Pathogenesis, molecular mechanisms, models, and emerging therapeutics
Rhema Khairnar, Md Asrarul Islam, Joshua S. Fleishman, et al.
Life Sciences (2022) Vol. 312, pp. 121185-121185
Closed Access | Times Cited: 27
Soluble epoxide hydrolase inhibitors: an overview and patent review from the last decade
Malliga R. Iyer, Biswajit Kundu, Casey M. Wood
Expert Opinion on Therapeutic Patents (2022) Vol. 32, Iss. 6, pp. 629-647
Closed Access | Times Cited: 23
Microbiome-liver crosstalk: A multihit therapeutic target for liver disease
Jorum Kirundi, Sheida Moghadamrad, Camilla Urbaniak
World Journal of Gastroenterology (2023) Vol. 29, Iss. 11, pp. 1651-1668
Open Access | Times Cited: 15
Polyphenol-induced improvements in glucose metabolism are associated with bile acid signaling to intestinal farnesoid X receptor
Kevin M. Tveter, José A. Villa-Rodríguez, Alrick Cabales, et al.
BMJ Open Diabetes Research & Care (2020) Vol. 8, Iss. 1, pp. e001386-e001386
Open Access | Times Cited: 32
Polysaccharides from fermentedAsparagus officinaliswithLactobacillus plantarumNCU116 alleviated liver injuryviamodulation of glutathione homeostasis, bile acid metabolism, and SCFA production
Zhihong Zhang, Songtao Fan, Danfei Huang, et al.
Food & Function (2020) Vol. 11, Iss. 9, pp. 7681-7695
Closed Access | Times Cited: 32
From Liver Fat to Cancer: Perils of the Western Diet
Ju Youn Kim, Feng He, Michael Karin
Cancers (2021) Vol. 13, Iss. 5, pp. 1095-1095
Open Access | Times Cited: 29
Emerging Role of Nuclear Receptors for the Treatment of NAFLD and NASH
Ryan D. Welch, Cyrielle Billon, McKenna Losby, et al.
Metabolites (2022) Vol. 12, Iss. 3, pp. 238-238
Open Access | Times Cited: 20
Gypenosides ameliorate high-fat diet-induced non-alcoholic steatohepatitis via farnesoid X receptor activation
Hongshan Li, Yingfei Xi, Hongliang Liu, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 19
Impaired flux of bile acids from the liver to the gut reveals microbiome-immune interactions associated with liver damage
Howell Leung, Ling Xiong, Yueqiong Ni, et al.
npj Biofilms and Microbiomes (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 10
Bile Acid Receptor Therapeutics Effects on Chronic Liver Diseases
Vik Meadows, Lindsey Kennedy, Debjyoti Kundu, et al.
Frontiers in Medicine (2020) Vol. 7
Open Access | Times Cited: 29
Page 1 - Next Page

Scroll to top